ADDF-Harrington Scholar Program
Program Seeks to Understand and Treat Alzheimer’s Disease
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute have partnered to form the ADDF-Harrington Scholar program. The program recognizes physicians or scientists across the US, Canada and the United Kingdom, who are doing research to develop drugs to prevent, treat and cure Alzheimer’s disease. The award provides funding and drug development support to help bridge the gap between basic discovery and the clinical realm.
Up to three ADDF-Harrington Scholar awards are made each year through a competitive selection process.